Prometheus Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Prometheus Biosciences's estimated annual revenue is currently $2.6M per year.
- Prometheus Biosciences's estimated revenue per employee is $20,984
- Prometheus Biosciences's total funding is $451.8M.
- Prometheus Biosciences's current valuation is $1.4B. (January 2022)
Employee Data
- Prometheus Biosciences has 122 Employees.
- Prometheus Biosciences grew their employee count by 0% last year.
Prometheus Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | VP - Precision Bioinformatics | Reveal Email/Phone |
2 | General Counsel | Reveal Email/Phone |
3 | VP, Biostatistics & Data Management | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Associate Director, Biobanking Operations | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Director Data Management | Reveal Email/Phone |
8 | Chief Operating Officer | Reveal Email/Phone |
9 | Director, Data Science and Engineering | Reveal Email/Phone |
10 | Senior Director, Immunology Discovery & Translational Sciences | Reveal Email/Phone |
Prometheus Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Prometheus Biosciences?
Prometheus Biosciences, Inc., is a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases.
keywords:N/A$451.8M
Total Funding
122
Number of Employees
$2.6M
Revenue (est)
0%
Employee Growth %
$1.4B
Valuation
N/A
Accelerator
Prometheus Biosciences News
In trading on Monday, shares of Prometheus Biosciences Inc (Symbol: RXDX) crossed below their 200 day moving average of $31.68,...
... Cornerstones Health, and Imedex; and as a consultant or adviser to Boehringer Ingelheim, Gilead Sciences, Prometheus Biosciences, Takeda, UCB Biopharma,...
Prometheus Biosciences Initiates Third Phase 2 Study of PRA023 for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD).
SAN DIEGO, Dec. 15, 2020 /PRNewswire/ -- Prometheus Biosciences, Inc. ("Prometheus"), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the diagnosis and treatment of ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 122 | 10% | N/A |
#2 | $37.8M | 122 | 0% | $18.6M |
#3 | $35M | 122 | 2% | N/A |
#4 | $33.6M | 122 | 5% | N/A |
#5 | $33.2M | 123 | -2% | N/A |